Received Jul 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
She began treatment with pneumococcal vaccination; This literature report has been received from the authors of the published article and refers to a 44-year-old female patient. The patient's medical history included childhood asthma, uncontrolled type 2 diabetes mellitus, osteomalacia with spontaneous rib fractures, Cushing's syndrome post-transsphenoidal pituitary resection, adrenocortical insufficiency, left lower lobe resection for mucinous adenocarcinoma in situ. The patient's concurrent conditions included asthma. The patient's concomitant medications included LAMA-LABA-ICS therapy and nasal irrigation. On unspecified date, the patient received treatment with pneumococcal vaccination (unknown vaccine) (dose, strength, route of administration, lot #, and expiration date were not provided) as an asthma treatment (product use in unapproved indication).
Asthma (recurred and worsened over the past seven years)
Medical History/Concurrent Conditions: Adenocarcinoma (left lower lobe resection); Adrenal cortical insufficiency (managed with hydrocortisone); Childhood asthma (resolved in adolescence); Cushing's syndrome; Osteomalacia; Spontaneous bone fracture; Transsphenoidal surgery; Type 2 diabetes mellitus